Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Osmotica Pharmaceutical

Osmotica Pharmaceutical
1986 FOUNDED
PUBLIC STATUS
401-500 EMPLOYEES
OSMT STOCK SYMBOL
2 INVESTMENTS
$4.14 SHARE PRICE (As of Thursday Closing)
Description

Osmotica Pharmaceuticals PLC is a fully-integrated biopharmaceutical company. It is focused on developing, manufacturing and commercializing specialty products. The product portfolio of the group includes specialty neurology and women's health products, which are primarily complex formulations of generic drugs.

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 400 Crossing Boulevard
  • Bridgewater, NJ 08807
  • United States

+1 (908) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Osmotica Pharmaceutical’s full profile, request a free trial.

Osmotica Pharmaceutical Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.20 - $9.90 $217M $4.11 -$4.62 87.6K 52.5M

Osmotica Pharmaceutical Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 411,213 691,153
Revenue 246,700 263,701 245,749 218,460
EBITDA (167,869) (16,301) (10,140) (8,295)
Net Income (241,665) (109,396) (41,142) (41,821)
Total Assets 643,835 795,645 919,740 978,500
Total Debt 275,178 268,834 320,686 329,025
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Osmotica Pharmaceutical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Osmotica Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

Osmotica Pharmaceutical Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cure Pharmaceutical Angel-Backed Oxnard, CA 00 0000 00000 0000
000000 000000 0000 Corporation Toronto, Canada 00 0000000000
00000000 Corporate Backed or Acquired Basel, Switzerland 000000 000000000000
00000000 000000000 Formerly PE-Backed Bridgewater, NJ 000000000000
0000000000 0000000 Private Equity-Backed Sarasota, FL 00 000000000000
To view this company’s complete list of competitors, request access »

Osmotica Pharmaceutical Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 01-Jan-2017 000000000000000000 000.00 Drug Discovery 00000 00000000
Vertical Pharmaceuticals 01-Dec-2013 Buyout/LBO Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

Osmotica Pharmaceutical Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000000 Pharmaceuticals Bridgewater, NJ 0000
To view this company’s complete subsidiary history, request access »

Osmotica Pharmaceutical Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Osmotica Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

Osmotica Pharmaceutical Executive Team (4)

Name Title Board
Seat
Contact
Info
Andrew Einhorn Chief Financial Officer & Chief Accounting Officer
Brian Markison Chief Executive Officer & Chairman

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »

Osmotica Pharmaceutical Board Members (3)

Name Representing Role Since Contact
Info
00000 00000000 Self Chief Executive Officer & Chairman 000 0000
0000000 00000 Self Board Member 000 0000

1 Former Board Member

You’re viewing 2 of 3 board members. Get the full list »